Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis

NCT: NCT06887842 · COMPLETED

NCT IDNCT06887842
StatusCOMPLETED
Start Date2025-04-25
Completion2026-05-01

Brief Summary

This study aims to compare the outcomes of posterior nasal nerve neurectomy in patients with resistant Allergic rhinitis by using three different methods ( surgical resection vs radiofrequency ablation vs surface coblation ) through assesment of functional outcomes, postoperative complications, and impacts on quality of life.

Frequently Asked Questions

What is Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis?

Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis is a clinical trial registered under NCT06887842. Current status: COMPLETED.

What is the status of NCT06887842?

The current status of NCT06887842 (Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis) is: COMPLETED.

When did Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis start?

Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis started on 2025-04-25.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑